Developing Intermediary Medication Phenotypes via Metabolomics Biotechnology Using an Electronic Health Record-Linked Biobank
Matthew K. Breitenstein$lastName;
Richard M. Weinshilboum$lastName;
Jyotishman Pathak$lastName;
Liewei Wang$lastName
You must log in to view this content. All contents are accessible to AMIA members and meeting attendees. If you are interested in purchasing proceedings, please contact us at mail@amia.org